Shkreli Short-Squeeze In KaloBios Executed To Perfection?

By: via Benzinga
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) shares are trading higher by $10 at $36.63 in Friday's session. Current and potential ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.